In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Artelo Biosciences (ARTL – Research
Author: Howard Kim
Leerink Partners Keeps a Buy Rating on Mirum Pharmaceuticals (MIRM)
In a report released yesterday, Mani Foroohar from Leerink Partners reiterated a Buy rating on Mirum Pharmaceuticals (MIRM – Research
Chardan Capital Reiterates Their Buy Rating on Vincera Pharma (VINC)
Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Vincera Pharma (VINC – Research Report) today and set a
Gilead Sciences (GILD) Gets a Hold Rating from Raymond James
Raymond James analyst Steven Seedhouse maintained a Hold rating on Gilead Sciences (GILD – Research Report) yesterday. The company’s shares
Analysts Conflicted on These Healthcare Names: Incyte (NASDAQ: INCY) and Masimo (NASDAQ: MASI)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY – Research Report)
AngioDynamics (ANGO) Receives a Buy from Raymond James
In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on AngioDynamics (ANGO – Research Report).
Raymond James Believes Fortress Transportation (NYSE: FTAI) Won’t Stop Here
In a report released today, Robert Dodd from Raymond James maintained a Buy rating on Fortress Transportation (FTAI – Research